Haemonetics (HAE) Tops Q3 EPS by 18c, Revenues Beat; Raises FY20 EPS Guidance Above Consensus
Go back to Haemonetics (HAE) Tops Q3 EPS by 18c, Revenues Beat; Raises FY20 EPS Guidance Above Consensus| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 90.07 -0.31 (0.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $90.38 | 52 Week High | $39.41 | |||
| Open | $90.61 | 52 Week Low | $25.98 | |||
| Day High | $91.49 | P/E | 126.86 | |||
| Day Low | $90.00 | EPS | $0.71 | |||
| Volume | 9,489 | |||||
